HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma. - Test2 - elhamkhani - TriplyDB

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

http://www.wikidata.org/entity/Q33618428

about

Mesothelioma: recent highlights.The dual role and therapeutic potential of high-mobility group box 1 in cancer.New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.Biomarkers in the prevention and follow-up of workers exposed to asbestos.Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer Specimen.Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine

P2860

Q33871606-6954B1FC-4AAE-4F31-B131-F365A658197D Q42362799-3954161B-A26C-44A2-9D97-A3E01C105877 Q52581757-722E8051-8737-4A88-8523-11AB89258A91 Q52672882-2D81A400-6636-4D63-A554-54E8703A4310 Q55284109-F888C56E-DDE1-43D9-9E3F-AFDA2613DBEA Q55286714-970624BE-3B9B-4D27-92A2-5DB8A21C8B6D Q57461758-CD0C1351-E700-44F7-8D30-3ED4B4E376E2

P2860

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

http://www.wikidata.org/entity/Q33618428

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

@ast

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

@en

type

label

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

@ast

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

@en

prefLabel

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

@ast

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

@en

P1433

Q33618428-403E5EEC-C0D3-43D7-A096-B83F4D26B4D5

P1476

Q33618428-E256D95B-EE59-4D1F-826A-4CB29CC3F607

P2093

Q33618428-2274BD48-F6C0-40FD-A33F-4C291605A1C0

Q33618428-2F3E9F9A-0FBD-4D41-8283-F4AF658BC5C3

Q33618428-38492624-79D5-423B-97A8-5BC50FC2AB97

Q33618428-3FAF26CC-06C7-46B7-9224-05ECAAE1300B

Q33618428-4170AF7C-CC24-470C-A686-64ED15A87844

Q33618428-44DDB535-DC72-4CBD-B03D-B0A05FF5C02E

Q33618428-4D4A6F50-1D63-49D0-A183-16CB4DBD4465

Q33618428-9291DB5C-A36A-42B1-A63F-265E35B6CBBF

Q33618428-9CEA6C74-BAD7-441B-844F-698FB972FFF0

Q33618428-AD5E76D9-23B3-4D06-91EF-F82B345E4B7F

P2860

Q33618428-03CEB8F5-DB98-4C10-ACD9-B6C02E0CC8A9

Q33618428-04A615F2-3E65-4169-B70A-105B30A918F4

Q33618428-0BC603BD-7ED3-43A0-82CB-7446BD1E691B

Q33618428-1434DF08-3ED1-4A05-A704-50F7D5289830

Q33618428-17D994F4-D2CA-450C-A9C3-6C780C65AE9B

Q33618428-1AC3E5DF-8B82-4B51-9BD1-8F7F5F118336

Q33618428-1C7095EE-4C9A-4F13-A807-631C78A3075D

Q33618428-26CE32E0-8E92-45CA-B6A0-1022E6EF53DC

Q33618428-29F0A476-25BD-4B85-8B16-2F677A7F6760

Q33618428-2CC146FF-CB38-4B25-B9EF-D74CD0755440

P304

Q33618428-2CC0FF07-4A02-4E2E-B766-518FCB2554B2

P31

Q33618428-F4A11CEC-2976-4F4D-8693-B629B5F59F03

P356

Q33618428-54BFF378-B538-4FEB-B37F-E2D6D843AD9D

P407

Q33618428-03602A11-ECB0-44C7-97C3-BD430E4F636D

P433

Q33618428-3757078D-7C1B-47BF-A271-B5913FB2D811

P478

Q33618428-2F52D90F-1A5B-4F0D-9B25-28FC2315CDCB

P50

Q33618428-00C047C8-430D-421F-BBF0-D76AEC93997A

Q33618428-01B9C2E4-6E6D-4A77-BE38-CBE2F9EA85D3

Q33618428-37D2BD47-85FD-4BBE-AB1E-52A9317E491C

P577

Q33618428-9968A6F8-F8AE-40ED-9D85-376E96694038

P698

Q33618428-C88C4C3E-ACFA-4752-91AA-90E827FFAA0D

P932

Q33618428-782BDD5B-4BA9-4278-84DF-A9388FD1E94E

P356

ONCOTARGET.15152

P1433

P1476

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

@en

P2093

David Larson

http://www.w3.org/2001/XMLSchema#string

Giovanni Gaudino

http://www.w3.org/2001/XMLSchema#string

Haining Yang

http://www.w3.org/2001/XMLSchema#string

Harvey I Pass

http://www.w3.org/2001/XMLSchema#string

Ian Pagano

http://www.w3.org/2001/XMLSchema#string

Jiaming Xue

http://www.w3.org/2001/XMLSchema#string

Kelly H Forest

http://www.w3.org/2001/XMLSchema#string

Michele Carbone

http://www.w3.org/2001/XMLSchema#string

Paul Morris

http://www.w3.org/2001/XMLSchema#string

Sandra Pastorino

http://www.w3.org/2001/XMLSchema#string

P2860

High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma

Ranpirnase Interferes with NF-κB Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth

Germline BAP1 mutations predispose to malignant mesothelioma

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

HMG-1 as a late mediator of endotoxin lethality in mice

HMGB1 and RAGE in inflammation and cancer

Masquerader: high mobility group box-1 and cancer

Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma

TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis

Malignant mesothelioma: facts, myths, and hypotheses

P304

22649-22661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.15152

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Andrea Napolitano

Marco E. Bianchi

Laura Pellegrini

P577

2017-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28186988

http://www.w3.org/2001/XMLSchema#string

P932

5410252

http://www.w3.org/2001/XMLSchema#string